Travere Therapeutics

ISIN US89422G1076

WKN A2QHYP

Market cap (in EUR)

4,540 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	4,540 m
EPS, EUR	-0.46
P/B ratio	52.0
P/E ratio	-
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	435 m
Net income, EUR	-45 m
Profit margin	-10.24%

What ETF is Travere Therapeutics in?

There are 31 ETFs which contain Travere Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Travere Therapeutics is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc)	0.06%	Equity United States Small Cap	86
Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Acc	0.02%	Equity World Small Cap Climate Change	472
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc	0.01%	Equity United States Multi-Factor Strategy	8
Xtrackers Portfolio UCITS ETF 1C	0.00%	Equity World Multi-Asset Strategy	748
Xtrackers MSCI World Small Cap UCITS ETF 1D	0.05%	Equity World Small Cap	11
L&G Russell 2000 US Small Cap Quality UCITS ETF	0.08%	Equity United States Small Cap	189
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.06%	Equity United States Small Cap	225
UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.01%	Equity United States Multi-Factor Strategy	28
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.01%	Equity World Multi-Factor Strategy	216
iShares MSCI World Small Cap UCITS ETF	0.04%	Equity World Small Cap	7,348
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C	0.15%	Equity World Health Care Social/Environmental	24
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.04%	Equity World Small Cap	45
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD	0.11%	Equity United States Small Cap	4,611
Xtrackers MSCI Global Social Fairness Contributors UCITS ETF 1C	0.03%	Equity World Social/Environmental	3
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Acc)	0.00%	Equity World	6,591
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc	0.06%	Equity United States Small Cap	44
UBS MSCI USA Select Factor Mix UCITS ETF USD acc	0.01%	Equity United States Multi-Factor Strategy	108
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc)	0.04%	Equity World Small Cap	1,675
Xtrackers Russell 2000 UCITS ETF 1C	0.13%	Equity United States Small Cap	2,388
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Dist)	0.00%	Equity World	173
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc	0.01%	Equity United States Multi-Factor Strategy	24
Xtrackers MSCI Global SDGs UCITS ETF 1C	0.11%	Equity World Social/Environmental	6
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.06%	Equity United States Small Cap	2,707
Xtrackers MSCI World Small Cap UCITS ETF 1C	0.05%	Equity World Small Cap	127
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.35%	Equity United States Health Care Biotech	65
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.01%	Equity World Multi-Factor Strategy	1,335
iShares Nasdaq US Biotechnology UCITS ETF	0.35%	Equity United States Health Care Biotech	957
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF USD	0.00%	Equity United States Small Cap	959
iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETF USD (Acc)	0.03%	Equity World Small Cap	396
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc	0.06%	Equity United States Small Cap	44
L&G Pharma Breakthrough UCITS ETF	4.28%	Equity World Health Care Innovation	20

Change your settings